07 May Cellular Logistics Expands Management Team
MADISON, Wis., May 7, 2019 – Cellular Logistics Inc., the UW-Madison spinoff focused on delivering new ways to treat heart failure and restore heart function, today announced the appointment of Alex Vodenlich as president and chief executive. Mr. Vodenlich also will join the company’s board of directors.
Mr. Vodenlich brings 25 years of experience in startup and early-stage life science companies to his new role at Cellular Logistics. He was chief executive of KromaTiD Inc., and president and chief executive of Gentel Biosciences Inc. Mr. Vodenlich most recently was vice president of sales and marketing at Lucigen Corp. before its acquisition by LGC Biosearch Technologies. He also held senior leadership positions at Cellara LLC, where he continues to serve on the company’s board of directors, and PanVera Corp. Early in his career, Mr. Vodenlich held scientific positions at Abbott Laboratories and Pfizer Inc. He holds bachelor’s and master’s degrees from UW-Madison in medical microbiology and bacteriology.
“We are thrilled to have Alex join the leadership team at Cellular Logistics Inc,” said Amish Raval, M.D., UW-Madison researcher and co-founder of CL. “He comes with significant leadership and commercialization experience in the life sciences and will help us accelerate the development and commercialization of our products,”
The company also announced that Paul Resnick, M.D., has joined its board of directors and Scott Fisher, Ph.D., has joined its scientific advisory board.
Dr. Resnick is an executive with broad leadership experience that spans large pharmaceutical and biotechnology companies. He serves as chief business officer of Biolojic Design Inc. and previously held senior business development positions at Rinat Neuroscience Corp., Pfizer Inc., Intellkine Inc., and Juventas Therapeutics Inc. Dr. Resnick earned his medical degree from the Medical College of Wisconsin and a Master of Business Administration from the Wharton School of the University of Pennsylvania.
Dr. Fisher is a product development expert with more than 20 years’ experience delivering clinical trial data in multiple therapeutic areas. He is an executive-in-residence at BioEnterprise in Cleveland and the chief executive of CavoGene LifeSciences. Scott earned his bachelor’s degree at the University of Dayton, a master’s degree at Ohio State University and his doctorate at the University of Maryland, where he was an NIH pre-doctoral fellow. He was the first ever Rathmann Family Foundation post-doctoral fellow at the University of Maryland-Baltimore Office of Research and Development and the Baltimore Veterans’ Affairs Medical Center.
“We are appreciative that Dr. Resnick and Dr. Fisher have joined their respective Cellular Logistics’ boards,” Mr. Vodenlich said. “Both will make significant contributions to the planning and execution of our product development and commercialization efforts. We look forward to working with them at this important time in the company’s development,” Mr. Vodenlich said.